Cite this: Rasagiline: A Second-Generation Monoamine Oxidase Type-B Inhibitor for the Treatment of Parkinson's Disease - Medscape - May 15, 2006.

These 11 everyday foods can interfere with common medications—learn what to avoid and how to protect your health.

On the latest edition of the JRE Fight Companion, Joe Rogan spoke to his close friend, ex-UFC heavyweight Brendan Schaub about his use of monoamine oxidase inhibitors (MAOIs).

News Release 27-Feb-2025 Coumarin derivatives as inhibitors against monoamine oxidase: Structure-activity relationships and inhibitory mechanisms Peer-Reviewed Publication Compuscript Ltd ...

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders.

The objective of this review is the determination of tyramine in 13 nonalcoholic beers (Maoshaieer) of Tehran market and survey of it’s probably interaction with monoamine oxidase inhibitor drugs ...

Scientists from Plant & Food Research and Callaghan Innovation have discovered that a novel bioactive compound, sarmentosin, is a naturally occurring Monoamine oxidase-B (MAO-B) inhibitor. MAO-B ...

Monoamine oxidase inhibitors (MAOIs) change the levels of the brain chemicals norepinephrine, serotonin and dopamine called neurotransmitters. Known as neurotransmitters, their job is to keep your ...

The link was discovered in the 1950s when doctors began prescribing monoamine oxidase inhibitors (MAOIs) for depression. Some patients complained of headaches and symptoms of high blood pressure ...

SINCE iproniazid was shown to be an effective monoamine oxidase inhibitor by Zeller et al. 1 in 1952 there has been extensive use of monoamine oxidase inhibitors, particularly in psychiatric ...

Monoamine oxidase inhibitors (MAOIs) have a long and prosperous history as medications for major depressive disorder (MDD). But this type of antidepressant has mostly seen its day.